TGFBR1 and kidney disorder: Notably, mitigating the mitochondrial injury in GECs also attenuated TGFBR1-induced podocyte loss in transgenic mice, underscoring the intricate involvement of crosstalk between signaling pathways and between glomerular cells and in kidney disease development.